[125I]angiotensin-(1-7) (human, mouse, rat) [7579]
[125I]angiotensin-(1-7) (human, mouse, rat)
| SMILES |
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)O |
| InChIKey |
PVHLMTREZMEJCG-GDTLVBQBSA-N |
| Sequence |
DRVYIHP |
| HELM |
PEPTIDE1{D.R.V.Y.I.H.P}$$$$ |
Chemical Properties
| Hydrogen bond acceptors |
12 |
| Hydrogen bond donors |
12 |
| Rotatable bonds |
25 |
| Log P |
-2.042 |
| Molecular weight (Da) |
898.5 |
| Stereochemistry info |
partial |
| Radioactive |
125I |
Bioactivities
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
[125I]angiotensin-(1-7) (human, mouse, rat)
Drug properties
| Molecular type |
Peptide |
| Physiological/Surrogate |
Surrogate |
| Approved drug |
No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Compound is not listed as a drug.